72
Participants
Start Date
March 31, 2025
Primary Completion Date
February 20, 2026
Study Completion Date
August 20, 2026
B7A (ETEC challenge strain)
A pathogenic strain of ETEC that can cause illness ranging from mild watery diarrhea to severe symptoms. The primary complication associated with an infection from this strain is dehydration.
CssBA
A CS6 based vaccine against ETEC (Enterotoxigenic Escherichia coli) in preventing moderate-severe diarrhea obtained via purification from a host E. coli expression strain, BL21(DE3), harboring a pET24a (+) plasmid containing the CssBA gene expressing the his-tagged CssBA protein.
dmLT
An E. coli double mutant heat labile toxin. This genetically attenuated strain is expressed from a plasmid (pLC403) in the E. coli expression strain JM83.
Placebo
Placebo
RECRUITING
University of Maryland, School of Medicine, Center for Vaccine Development and Global Health, Baltimore
RECRUITING
Cincinnati Children's Hospital Medical Center Vaccine Research Center, Cincinnati
National Institute of Allergy and Infectious Diseases (NIAID)
NIH